A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

NCT05157958 ·Status: RECRUITING ·Phase: PHASE2

Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro

NCT06177353 ·Status: RECRUITING

Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa

NCT04727268 ·Status: UNKNOWN

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

NCT00904163 ·Status: COMPLETED

A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

NCT02810951 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Computational Drug Repurposing for All EBS Cases

NCT03269474 ·Status: RECRUITING

Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

NCT01874769 ·Status: COMPLETED

A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

NCT05708677 ·Status: ENROLLING_BY_INVITATION

Establishment of the National Epidermolysis Bullosa Registry

NCT00004761 ·Status: COMPLETED

A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa

NCT04599881 ·Status: COMPLETED ·Phase: PHASE2

Artificial Intelligence Patient App for RDEB SCCs

NCT05843994 ·Status: ACTIVE_NOT_RECRUITING

A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

NCT03752905 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

NCT06834035 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)

NCT05143190 ·Status: COMPLETED ·Phase: PHASE2

Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer

NCT00533572 ·Status: TERMINATED

Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

NCT03392909 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa

NCT04213261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Evaluation of D-Fi for the Treatment of Wounds Due to DEB

NCT06892639 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa

NCT04213703 ·Status: WITHDRAWN

Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa

NCT04285294 ·Status: UNKNOWN

Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa

NCT04217538 ·Status: COMPLETED

A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial

NCT03183934 ·Status: COMPLETED

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

NCT03016715 ·Status: UNKNOWN ·Phase: PHASE2

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

NCT02960997 ·Status: COMPLETED ·Phase: PHASE2

A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome

NCT05979831 ·Status: TERMINATED ·Phase: PHASE1/PHASE2